Published Date: 24 Aug 2026
— Doesn't matter whether it's in the first carpometacarpal or interphalangeal joints
AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate to treatment and reduced the risk of disease progression or death,...
For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.
A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.
A higher BMI is associated with a reduced response to JAK inhibitors in patients with rheumatoid arthritis.
A Q&A with Daphne Scott
Regimens may drop the direct anticoagulants for some patients, based on EPCAT III
The oral HER2 TKI was previously given accelerated approval in the second line for the indication.
Starting denosumab is associated with a modestly lower risk of developing osteoarthritis than starting oral bisphosphonates among adults with osteoporosis.
Pediatricians can and should screen for scoliosis, especially in teens who are still growing.
Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT
Mobility assistance devices may be harmful if not prescribed properly
Now it's up to clinicians to sort out conflicting evidence
But what drives the apparent effect remains unknown. Is it the weight loss or other factors?
There's little published research, but a small, flexible arthroscope is accumulating proponents
Also in TTHealthWatch: GLP-1 agonists and knee replacement
The tournament is a preview for how outdoor activities are being reshaped globally
The U.S. Food and Drug Administration declined to approve Swedish drugmaker Sobi's therapy to treat uncontrolled gout, a common form of inflammatory arthritis, the company...
Photo finish after 10 years in randomized trial, but a winner is identified
Daily news to keep you up to date
Gain valuable insights with our in-depth KOL Video discussions
Participate and win cash vouchers
Get updates on the latest events happening around the world
Fastest Growing Medical Platform for Doctors
Address : Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone : +1-415-463-3094
Email : anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
To get started please enter your email ID
By entering your details you agree to our
Please check your email for the four-digit security code and enter it below.
Didn't receive a code? Resend OTP
Join to enhance your clinical skills and gain specialized in-depth medical knowledge
Country
State